125 related articles for article (PubMed ID: 35997154)
1. Discovery of novel potential inhibitors of TMPRSS2 and Mpro of SARS-CoV-2 using E-pharmacophore and docking-based virtual screening combined with molecular dynamic and quantum mechanics.
Mahgoub MA; Alnaem A; Fadlelmola M; Abo-Idris M; Makki AA; Abdelgadir AA; Alzain AA
J Biomol Struct Dyn; 2023; 41(14):6775-6788. PubMed ID: 35997154
[TBL] [Abstract][Full Text] [Related]
2. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
[TBL] [Abstract][Full Text] [Related]
3. Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease.
Varadharajan V; Arumugam GS; Shanmugam S
J Biomol Struct Dyn; 2022 Oct; 40(17):7852-7867. PubMed ID: 33764269
[TBL] [Abstract][Full Text] [Related]
4. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
Kundu D; Selvaraj C; Singh SK; Dubey VK
J Biomol Struct Dyn; 2021 Jun; 39(9):3428-3434. PubMed ID: 32362243
[TBL] [Abstract][Full Text] [Related]
5. Exploring potential SARS-CoV-2 Mpro non-covalent inhibitors through docking, pharmacophore profile matching, molecular dynamic simulation, and MM-GBSA.
Shi Y; Dong L; Ju Z; Li Q; Cui Y; Liu Y; He J; Ding X
J Mol Model; 2023 Apr; 29(5):138. PubMed ID: 37055578
[TBL] [Abstract][Full Text] [Related]
6. Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation.
Prajapati J; Patel R; Goswami D; Saraf M; Rawal RM
Comput Biol Med; 2021 Aug; 135():104568. PubMed ID: 34174757
[TBL] [Abstract][Full Text] [Related]
7. Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M
Bekono BD; Onguéné PA; Simoben CV; Owono LCO; Ntie-Kang F
Eur Biophys J; 2024 Jun; ():. PubMed ID: 38907013
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening and structure-based 3D pharmacophore approach to identify small-molecule inhibitors of SARS-CoV-2 M
Elseginy SA
J Biomol Struct Dyn; 2022; 40(24):13658-13674. PubMed ID: 34676801
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi").
Cayona R; Creencia E
Med Chem; 2022; 18(3):364-381. PubMed ID: 34148541
[TBL] [Abstract][Full Text] [Related]
10. Identification of RdRp inhibitors against SARS-CoV-2 through E-pharmacophore-based virtual screening, molecular docking and MD simulations approaches.
Rehman HM; Sajjad M; Ali MA; Gul R; Naveed M; Aslam MS; Shinwari K; Bhinder MA; Ghani MU; Saleem M; Rather MA; Ahmad I; Amin A
Int J Biol Macromol; 2023 May; 237():124169. PubMed ID: 36990409
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.
Abdizadeh R; Hadizadeh F; Abdizadeh T
J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354
[TBL] [Abstract][Full Text] [Related]
12. Exploration of Novel Lichen Compounds as Inhibitors of SARS-CoV-2 Mpro: Ligand-Based Design, Molecular Dynamics, and ADMET Analyses.
Gupta A; Sahu N; Singh AP; Singh VK; Singh SC; Upadhye VJ; Mathew AT; Kumar R; Sinha RP
Appl Biochem Biotechnol; 2022 Dec; 194(12):6386-6406. PubMed ID: 35921031
[TBL] [Abstract][Full Text] [Related]
13. Investigation of bio-active Amaryllidaceae alkaloidal small molecules as putative SARS-CoV-2 main protease and host TMPRSS2 inhibitors: interpretation by
Bhowmick S; Mistri TK; Khan MR; Patil PC; Busquets R; Ashif Ikbal AM; Choudhury A; Roy DK; Palit P; Saha A
J Biomol Struct Dyn; 2023 Jul; ():1-21. PubMed ID: 37482789
[TBL] [Abstract][Full Text] [Related]
14. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.
Gupta Y; Kumar S; Zak SE; Jones KA; Upadhyay C; Sharma N; Azizi SA; Kathayat RS; Poonam ; Herbert AS; Durvasula R; Dickinson BC; Dye JM; Rathi B; Kempaiah P
Bioorg Med Chem; 2021 Oct; 47():116393. PubMed ID: 34509862
[TBL] [Abstract][Full Text] [Related]
15. In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis.
Gajjar ND; Dhameliya TM; Shah GB
J Mol Struct; 2021 Sep; 1239():130488. PubMed ID: 33903778
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ
Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228
[TBL] [Abstract][Full Text] [Related]
17. Exploiting the co-crystal ligands shape, features and structure-based approaches for identification of SARS-CoV-2 Mpro inhibitors.
Yousaf N; Jabeen Y; Imran M; Saleem M; Rahman M; Maqbool A; Iqbal M; Muddassar M
J Biomol Struct Dyn; 2023; 41(23):14325-14338. PubMed ID: 36946192
[TBL] [Abstract][Full Text] [Related]
18. Using Chou's 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors.
Pundir H; Joshi T; Joshi T; Sharma P; Mathpal S; Chandra S; Tamta S
Mol Divers; 2021 Aug; 25(3):1731-1744. PubMed ID: 33079314
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening and molecular simulation study of natural products database for lead identification of novel coronavirus main protease inhibitors.
Tripathi N; Goel B; Bhardwaj N; Sahu B; Kumar H; Jain SK
J Biomol Struct Dyn; 2022 May; 40(8):3655-3667. PubMed ID: 33213294
[TBL] [Abstract][Full Text] [Related]
20. In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2.
Byadi S; Oblak D; Kassmi Y; Sadik K; Hachim ME; Podlipnik Č; Aboulmouhajir A
J Biomol Struct Dyn; 2023 Apr; 41(7):2900-2910. PubMed ID: 35168469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
